GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis

Author： Acosta-Colman Isabel Palau Núria Tornero Jesús Fernández-Nebro Antonio Blanco Francisco González-Alvaro Isidoro Cañete Juan D Maymó Joan Ballina Javier Fernández-Gutiérrez Benjamín Olivé Alex Corominas Héctor Erra Alba Canela-Xandri Oriol Alonso Arnald López Lasanta Maria Tortosa Raül Julià Antonio Marsal Sara

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.7, 2013-05, pp. : 727-734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-TNF Treatment in Rheumatoid Arthritis

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3141-3151

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH Toonen Erik JM Scheffer Hans Radstake Timothy RDJ Barrera Pilar Franke Barbara

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite

Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature

By Birnbaum Howard Shi Lizheng Pike Crystal Kaufman Rebecca Sun Peter Cifaldi Mary

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 255-269

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J Allanore Y

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite

TNF inhibition as therapy for rheumatoid arthritis

By Wollheim Frank A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 947-953

Informa Healthcare

Access to resources Recommend Favorite